Jeong Jeung Yeol, Chung Pill Ku, Yoo Jae Chul
Department of Orthopedic Surgery, Sungkyunkwan University College of Medicine, Samsung Medical Center, Seoul, Republic of Korea.
J Orthop Surg (Hong Kong). 2017 May-Aug;25(2):2309499017718908. doi: 10.1177/2309499017718908.
Hyaluronate-based anti-adhesive agents are expected to enhance rotator cuff healing; however, their effect on the incidence and extent of postoperative complications such as stiffness and retears has not been investigated.
From July 2012 to February 2013, 80 patients undergoing arthroscopic rotator cuff repair surgery were prospectively enrolled. Forty patients were assigned to the control group, while the other 40 were assigned to the injection group and received a Guardix-sol injection immediately after surgery. Passive range of motion, pain visual analog scale, and functional score were assessed at 8 weeks, 6 months, and 24 months postoperatively. Gliding motion between the deltoid muscle and the greater tuberosity of the proximal humerus was evaluated using ultrasonography at 2 and 8 weeks postoperatively, and tendon integrity was evaluated using magnetic resonance imaging at 6 months postoperatively.
We found no significant difference between the groups regarding gliding motion at 2 weeks postoperatively. However, at 8 weeks, the incidence of poor gliding motion was 2.5% and 15% for the injected patients and control group, respectively, which was statistically significant. At 6 months after surgery, the retear rate between the two groups was not statistically significant. We found no statistically significant difference between the two groups regarding retear rate and clinical score throughout the follow-up period. We noted no complications related to the use of Guardix-sol.
Patients who received the Guardix-sol injection showed improved gliding motion between the deltoid muscle and the greater tuberosity in the early postoperative period.
基于透明质酸盐的抗粘连剂有望促进肩袖愈合;然而,其对术后并发症(如僵硬和再撕裂)的发生率及程度的影响尚未得到研究。
2012年7月至2013年2月,前瞻性纳入80例行关节镜下肩袖修复手术的患者。40例患者被分配至对照组,另外40例被分配至注射组,术后立即接受Guardix-sol注射。在术后8周、6个月和24个月评估被动活动范围、疼痛视觉模拟评分和功能评分。术后2周和8周使用超声评估三角肌与肱骨近端大结节之间的滑动运动,术后6个月使用磁共振成像评估肌腱完整性。
我们发现两组术后2周时的滑动运动无显著差异。然而,在8周时,注射组患者和对照组的滑动运动不良发生率分别为2.5%和15%,具有统计学意义。术后6个月,两组之间的再撕裂率无统计学差异。在整个随访期间,两组之间的再撕裂率和临床评分无统计学显著差异。我们未发现与使用Guardix-sol相关的并发症。
接受Guardix-sol注射的患者在术后早期三角肌与大结节之间的滑动运动有所改善。